Febri Wulandari

Febri Wulandari

Auto-generated profile, based on publicly available information

Febri Wulandari

Cancer Chemoprevention Research Center, Faculty of Pharmacy, Universitas Gadjah Mada (UGM), Sekip Utara, Yogyakarta 55281, Indonesia

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 August 2021 in Research Journal of Pharmacy and Technology
Verified
Journal Article
Closed access
DNDhania Novitasari
Dhania Novitasari
RJRiris Istighfari Jenie
Riris Istighfari Jenie
FWFebri Wulandari
Febri Wulandari
RURohmad Yudi Utomo
Rohmad Yudi Utomo
DPDyaningtyas Dewi Pamungkas Putri
Dyaningtyas Dewi Pamungkas Putri
EMEdy Meiyanto
Edy Meiyanto

4 July 2021 in Advanced Pharmaceutical Bulletin
Verified
Journal Article
Open access
RURohmad Yudi Utomo
Rohmad Yudi Utomo
FWFebri Wulandari
Febri Wulandari
DNDhania Novitasari
Dhania Novitasari
BLBeni Lestari
Beni Lestari
RSRatna Asmah Susidarti
Ratna Asmah Susidarti
EMEdy Meiyanto
Edy Meiyanto
Purpose: This study aimed to challenge the anticancer potency of pentagamavunone-1 (PGV-1) and obtain a new compound (Chemoprevention-Curcumin Analog 1.1, CCA-1.1) withimproved chemical and pharmacological properties.Methods: CCA-1.1 was prepared by changing the ketone group of PGV-1 into a hydroxylgroup with NaBH4 as the reducing agent. The product was purified under preparative layerchromatography and confirmed with HPLC to show about 93% purity. It was tested for itssolubility, stability, and cytotoxic activities on several cancer cells. The structure of the productwas characterized using 1HNMR, 13C-NMR, FT-IR, and HR-mass spectroscopy.Results: Molecular docking analysis showed that CCA-1.1 performed similar or better interactionto NF-κB pathway-related signaling proteins (HER2, EGFR, IKK, ER-alpha, and ER-beta) andreactive oxygen species (ROS) metabolic enzymes (NQO1, NQO2, GSTP1, AKC1R1, andGLO1) compared with PGV-1, indicating that CCA-1.1 exhibits the same or better anticanceractivity than PGV-1. CCA-1.1 also showed better solubility and stability than PGV-1 in aqueoussolution at pH 1.0–7.4 under light exposure at room temperature. The cytotoxic activities ofCCA-1.1 against several (10) cancer cell lines revealed the same or better potency than PGV-1.Conclusion: In conclusion, CCA-1.1 performs better chemical and anticancer properties thanPGV-1 and shows promise as an anticancer agent with high selectivity.

3 May 2023 in Journal of Tropical Biodiversity and Biotechnology
Verified
Journal Article
Open access
PDF file
MIMuthi' Ikawati
Muthi' Ikawati
HMHajidah Musyayyadah
Hajidah Musyayyadah
YPYurananda Magnalia Putri
Yurananda Magnalia Putri
UZUmmi Maryam Zulfin
Ummi Maryam Zulfin
FWFebri Wulandari
Febri Wulandari
EMEdy Meiyanto
Edy Meiyanto
Pentagamavunone-1 (PGV-1) is a curcumin analog with a prominent anti-cancer potency in vitro and in vivo for several cancer types, including colon cancer. Combining PGV-1 with natural compounds such as diosmin, galangin, and piperine can enhance its effectiveness due to their promising chemoprevention properties. We aimed to evaluate the effectiveness of combining PGV-1 with diosmin, galangin, or piperine for colon cancer by using in vitro and bioinformatic approaches to predict their target proteins. WiDr cells were used as a model for colon adenocarcinoma (COAD). The cell viability under a single or combination treatment of PGV-1 and diosmin, galangin, or piperine was evaluated using direct counting by the trypan blue exclusion test. SwissTargetProtein, UALCAN, and OncoLnc were utilized to predict target proteins of the compounds in COAD, the expression level of target proteins in COAD, and the survival rate of patients with overexpressed target proteins, respectively. The IC50 values for PGV-1, diosmin, galangin, and piperine were 2.8´10-2 µg/mL, 81 µg/mL, 7 µg/mL, and 172 µg/mL, respectively. All the tested natural compounds showed synergistic effects when combined with PGV-1 at low concentrations. Eleven proteins that were overexpressed in COAD were identified as potential targets. Overlapped predicted targets of PGV-1 and galangin or piperine were CDK1, MET, and TOP2A. The high expression of another set of predicted target proteins, SCD, CA9, and SQLE, led to lower survival rates in COAD patients. We concluded that combinations of PGV-1 with natural compounds can synergistically enhane its anti-cancer activity for colon cancer.

15 June 2025 in International Journal of Applied Pharmaceutics
Verified
Journal Article
Open access
PDF file
PIPeni Indrayudha
Peni Indrayudha
FWFebri Wulandari
Febri Wulandari
KCKibedi Cabral
Kibedi Cabral
MGMuhammad Ia Af Ghani
Muhammad Ia Af Ghani
Objective: Pathogenic microorganisms, including bacteria, viruses, fungi, and parasites, are sources of infectious diseases. It is known that Nigella sativa contains nigellimine, nigellimine-N-oxide, nigellidine, and nigellicine, as well as other active alkaloid compounds. The purpose of this study was to examine the antibacterial activity and bioautography of the ethyl acetate fraction of Nigella sativa against Bacillus cereus, Shigella sonnei, Streptococcus mutans, and Klebsiella pneumoniae. Methods: Thin Layer Chromatography (TLC) was used in the bioautography analysis, and the disc diffusion technique was used to test the antibacterial activity. The concentrations of the ethyl acetate fractions were 20%, 40%, 60%, and 80%. Results: The ethyl acetate fraction of Nigella sativa showed strong antibacterial activity against a number of microorganisms studied. According to the data, the inhibition zone was the best at a concentration of 80%. The diameters of the inhibition zones for the following bacteria were measured: 11.08±0.38 mm for Klebsiella pneumoniae, 12.50±0.50 mm for Shigella sonnei, and 17.67±0.58 mm for Bacillus cereus, covering a disc diameter of 6.00 mm. The findings of the bioautography test indicated that the alkaloid component is most likely the active ingredient causing the antibacterial activity. Conclusion: Based on this research, the ethyl acetate fraction of Nigella sativa can be used as a natural antibacterial agent.